Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Raevens

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
Hepatology (Baltimore, Md.)|October 13, 2017
Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in miceSarah Raevens, Anja Geerts, Annelies Paridaens, et al.
Hepatology (Baltimore, Md.)|September 28, 2018
Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver DiseaseSander Lefere, Frederique Van de Velde, Anne Hoorens, et al.
The European Respiratory Journal|November 30, 2018
Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experienceSarah Raevens, Xavier Rogiers, Anja Geerts, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2026
Interleukin-8-Driven Monocyte Activation in Primary Sclerosing Cholangitis: Insights from Single-Cell Analysis and Humanized Immune System MiceLander Heyerick, Zenzi De Vos, Aline Baekelandt, et al.
American Journal of Respiratory Cell and Molecular Biology|April 28, 2026
Alveolar Type 2 Cell Dysfunction Is Associated with Bile Acid Alterations in Experimental Hepatopulmonary SyndromeHyo-Jin Park, Hyung Joon Cho, Peng Chen, et al.
JHEP Reports : Innovation in Hepatology|April 2, 2025
Hepatopulmonary syndrome in patients with porto-sinusoidal vascular disorder: Characteristics and outcomeSabrina Sidali, Ylang Spaes, Kinan El Husseini, et al.
Critical Care (London, England)|October 30, 2025
Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX studyKlaus Stahl, Bahar Nalbant, Thorben Pape, et al.
The Lancet. Gastroenterology & Hepatology|March 9, 2025
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort studyKavish R Patidar, Ann T Ma, Adrià Juanola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Real-world Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal SyndromeAnn T Ma, Adrià Juanola, Kavish R Patidar, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Hepatology (Baltimore, Md.)|October 13, 2017
Placental growth factor inhibition targets pulmonary angiogenesis and represents a therapy for hepatopulmonary syndrome in miceSarah Raevens, Anja Geerts, Annelies Paridaens, et al.
Hepatology (Baltimore, Md.)|September 28, 2018
Angiopoietin-2 Promotes Pathological Angiogenesis and Is a Therapeutic Target in Murine Nonalcoholic Fatty Liver DiseaseSander Lefere, Frederique Van de Velde, Anne Hoorens, et al.
The European Respiratory Journal|November 30, 2018
Outcome of liver transplantation for hepatopulmonary syndrome: a Eurotransplant experienceSarah Raevens, Xavier Rogiers, Anja Geerts, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2026
Interleukin-8-Driven Monocyte Activation in Primary Sclerosing Cholangitis: Insights from Single-Cell Analysis and Humanized Immune System MiceLander Heyerick, Zenzi De Vos, Aline Baekelandt, et al.
American Journal of Respiratory Cell and Molecular Biology|April 28, 2026
Alveolar Type 2 Cell Dysfunction Is Associated with Bile Acid Alterations in Experimental Hepatopulmonary SyndromeHyo-Jin Park, Hyung Joon Cho, Peng Chen, et al.
JHEP Reports : Innovation in Hepatology|April 2, 2025
Hepatopulmonary syndrome in patients with porto-sinusoidal vascular disorder: Characteristics and outcomeSabrina Sidali, Ylang Spaes, Kinan El Husseini, et al.
Critical Care (London, England)|October 30, 2025
Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX studyKlaus Stahl, Bahar Nalbant, Thorben Pape, et al.
The Lancet. Gastroenterology & Hepatology|March 9, 2025
Global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis: the International Club of Ascites GLOBAL AKI prospective, multicentre, cohort studyKavish R Patidar, Ann T Ma, Adrià Juanola, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 10, 2025
Real-world Use of Terlipressin in Cirrhosis and Acute Kidney Injury: Frequent Use Beyond Hepatorenal SyndromeAnn T Ma, Adrià Juanola, Kavish R Patidar, et al.
Pageof 6